Who has invested in Empirico?

Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures are named among the investors backing Empirico.

Empirico Funding: $75M Raised, Series B (2024)

Empirico funding overview

Empirico is based in San Diego. Empirico has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2024. The round record for Empirico runs through 2024; nothing later has been disclosed. Investors on record include Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures. 3 distinct backers are named across the disclosed rounds.

Empirico at a glance

Total raised: $75M
Latest round: Series B
Latest round date: July 2024
Headquarters: San Diego
Notable investors: Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures

Frequently asked about Empirico funding

How much has Empirico raised?: Empirico has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Empirico?: Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures are named among the investors backing Empirico.
What was the latest Empirico funding round?: The most recent disclosed round is a Series B, announced in July 2024.
Where is Empirico based?: Empirico is based in San Diego.
When did Empirico last raise?: The last disclosed Empirico round closed in July 2024 at Series B.

Empirico totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Empirico Funding: $75M Raised, Series B (2024)

Empirico funding overview

Empirico at a glance

Frequently asked about Empirico funding

Companies related to Empirico (18)

Browse related funding lists (6)